← Open Payments lookup

KEVIN CLEARMAN: Open Payments

NPI 1477557098 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,308 in 80 payments from 16 companies in 2025. Trend: 2023 $1,732 · 2024 $1,412 · 2025 $1,308

Food & beverage: $1,308
CompanyPaymentsAmount
ABBVIE INC.21$247
AstraZeneca Pharmaceuticals LP8$233
Novo Nordisk Inc19$213
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$151
Exact Sciences Corporation4$97
Amgen Inc.4$62
Lilly USA, LLC3$55
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Lundbeck LLC2$40
Bayer Healthcare Pharmaceuticals Inc.2$37

Products named: XIFAXAN, FARXIGA, VRAYLAR, QULIPTA, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, Rybelsus.

Industry payments across MS — which companies pay providers there.